Last Updated: June 11, 2026

PIOGLITAZONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pioglitazone, and what generic alternatives are available?

Pioglitazone is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Annora Pharma, Aurobindo Pharma Ltd, Chartwell Rx, Corepharma, Macleods Pharms Ltd, Pharmobedient, Prinston Inc, Puracap Pharm Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc. and is included in twenty-two NDAs.

The generic ingredient in PIOGLITAZONE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for PIOGLITAZONE?
  • What are the global sales for PIOGLITAZONE?
  • What is Average Wholesale Price for PIOGLITAZONE?
Summary for PIOGLITAZONE
US Patents:0
Applicants:13
NDAs:22
Drug Prices: Drug price information for PIOGLITAZONE
Drug Sales Revenues: Drug sales revenues for PIOGLITAZONE
What excipients (inactive ingredients) are in PIOGLITAZONE?PIOGLITAZONE excipients list
DailyMed Link:PIOGLITAZONE at DailyMed
Drug patent expirations by year for PIOGLITAZONE
Drug Prices for PIOGLITAZONE

See drug prices for PIOGLITAZONE

Drug Sales Revenue Trends for PIOGLITAZONE

See drug sales revenues for PIOGLITAZONE

US Patents and Regulatory Information for PIOGLITAZONE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Ltd PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 091298-002 Feb 13, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Prinston Inc PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 207806-002 Apr 17, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aurobindo Pharma Ltd PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 200823-002 Feb 13, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms Usa Inc PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 202456-003 Feb 13, 2013 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 091273-001 Apr 16, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmobedient PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 090406-002 Feb 25, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmobedient PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078472-002 Feb 13, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for PIOGLITAZONE
Can Pioglitazone cause fluid retention?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links